PATIENT PREFERENCE DCE STUDY IN ACTINIC KERATOSIS TREATMENTS

• Research type

  Research Study

• Full title

  PATIENT PREFERENCE Discrete Choice Experiment STUDY IN ACTINIC KERATOSIS TREATMENTS

• IRAS ID

  302992

• Contact name

  Terri Madison

• Contact email

  terri.madison@certara.com

• Duration of Study in the UK

  0 years, 4 months, 31 days

• Research summary

  A discrete choice experiment (DCE) is an economic methodolog to obtain relative preferences from respondents on a given set of characteristics of a product or a service (attributes) within a complex situation.
  Actinic keratosis (AK) is a dermatological disease that develops from years of exposure to the sun. It is most commonly found on the face, lips, ears and hands and it is considered as a precursor lesion for skin cancer. Current treatments are associated with several limitations and there is a general lack of high-quality preference research to value preferences for different treatments for AK. The aim of this study is to provide a better understanding of the patient and physician preferences for characteristics (attributes) of different treatments for AK. The study will be conducted in the UK, France, Germany, Spain, Italy, Sweden, Finland and Canada, using data collected via an online survey from patients and physicians to determine their preferences.
  Attributes (characteristics) of the treatments and the levels of each attribute (for example high,medium or low) have been identified via a literature review and through consultations with 6 dermatologists. The pilot phase of the study will be used to refine these attributes and levels before the main study is rolled out. The pilot phase is expected to recruit 60-80 respondents, and the main study a total of 400-500 respondents, 30% of which are dermatologists. A DCE will be designed and implemented in this study to measure societal preferences of AK treatments following a defined set of attributes.

• REC name

  Yorkshire & The Humber - Sheffield Research Ethics Committee

• REC reference

  21/YH/0213

• Date of REC Opinion

  13 Sep 2021

• REC opinion

  Further Information Favourable Opinion